Home » Archive by Category

Syndication

Ivera Medical Corporation Successfully Completes FDA Inspection

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, CA–(Marketwired – October 21, 2014) – Ivera Medical Corporation is pleased to report that it successfully completed several days of an exhaustive and intensive review by the Food and Drug Administration (FDA) of Ivera’s manufacturing practices, quality control and regulatory filings. At the conclusion of the inspection, which was prompted by a complaint filed…

AVACEN Medical Wins FDA Nod For First Medical Device With Internal Game Mode

October 22, 2014 – 5:00 am | Edit Post

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford FinanceMonitors Proper Device Use and Enhances Patient ComplianceSAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance…

Avacen Medical Wins FDA Nod For First Medical Device With Internal Game Mode

October 22, 2014 – 5:00 am | Edit Post

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford FinanceMonitors Proper Device Use and Enhances Patient ComplianceSAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance…

Kythera Biopharmaceuticals Grants Stock Options Under Inducement Program

October 22, 2014 – 5:00 am | Edit Post

WESTLAKE VILLAGE, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) — KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 17, 2014, the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase an aggregate of 28,500 shares of the Company…

Avacen Medical Wins FDA Nod For First Medical Device With Internal Game Mode

October 22, 2014 – 5:00 am | Edit Post

Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford FinanceMonitors Proper Device Use and Enhances Patient ComplianceSAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance…

aTyr Pharma Inc. Appoints As Vice President, Research

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO and HONG KONG, Oct. 22, 2014 /PRNewswire/ –aTyr Pharma (“aTyr”), an innovative rare disease therapeutics enterprise, announced today that rare disease expert John C. McKew, Ph.D., joined the company as vice president, research. Dr. McKew…

Paper Pak Industries Release: New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus

October 22, 2014 – 5:00 am | Edit Post

LA VERNE, Calif., Oct. 22, 2014 /PRNewswire/ –Paper Pak Industries, a manufacturer of innovative emergency readiness products, has developed APLS Body Guard Bio, a disposable, highly absorbent body bag that minimizes the spread of bacteria and virus while protecting service providers and the deceased…

Regulus Therapeutics, Inc. Release: A Single Subcutaneous Dose Of 2mg/Kg Of RG-101, Regulus’ Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction As Monotherapy At Day 29 In Patients With Varied HCV Genotypes And Treatment History

October 22, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 22, 2014 /PRNewswire/ –Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical…

BioNano Genomics’s Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 21, 2014 /PRNewswire/ –BioNano Genomics, the genome mapping company, announced today the latest genomics research centers to purchase an

Biomarker Discovery Company, Antigen Discovery Inc., Awarded An NIH Phase I Small Business Innovation Research Grant To Develop A Pan-HIV Protein Microarray Chip

October 22, 2014 – 5:00 am | Edit Post

IRVINE, Calif., Oct 22, 2014 /PRNewswire/ — Antigen Discovery Inc. (ADi), a privately held company in Irvine, California, announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Researchaward (SBIR) fromthe National Institute of Dental…